Privia Health Group, Inc.

Privia Health Group, Inc.

PRVANYSE / NASDAQHealthcareMid cap

$25.05+$0.36 (+1.5%)

Last close · Data as of Nov 20, 2026

Market cap
$2.7B
P/E
117.5x
EV / EBITDA
50.4x
Revenue
$2.1B
Net margin
1.1%
ROCE
4.3%

+11.1% over the last year

Privia Health Group, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+9.2%
3M
+18.2%
6M
+8.1%
1Y
+11.1%
5Y
-13.2%

52-week range

Day change +$0.36 (+1.5%) from $24.69 to $25.05 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in PRVA, bought on each weekday since 2021.

News & filings

What Privia Health Group filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthOperating profit was 32.0 times interest costs.

Concerns (1)

  • The P/E of 117.5 is more than four times the peer median of 12.1.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems.

Read moreShow less

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.

Sector
Healthcare
Shares outstanding
120.6M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$2.7B
P/E
117.5x
P/B
3.7x
EV / EBITDA
50.4x
EV / Sales
1.0x
P/S
1.3x
52-week high
$28.10
52-week low
$19.10

Profitability

Operating margin
1.6%
Net margin
1.1%
EBITDA margin
2.1%
ROE
3.1%
ROCE
4.3%
ROA
1.7%
Asset turnover
1.55

Growth

Revenue
$2.1B
Revenue growth, 1Y
22.3%
Revenue CAGR, 3Y
16.1%
Net profit growth, 1Y
59.3%
Free cash flow
$163.4M

Solvency

Current ratio
1.60
Debt / Equity
0.01
Debt / Assets
0.01
CFO / Net profit
7.13
Cash / Market cap
17.8%

Where the revenue went

Of every $100 of FY2025 revenue, $1 was left as net income.

Privia Health Group, Inc. income statement flow, FY2025
Privia Health Group, Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$1.9B
RevenueGross profit$209.4M
Gross profitSelling, general and administrative$165.3M
Gross profitOther operating expenses$9.9M
Gross profitOperating income$34.2M
Operating incomePretax income$34.2M
Interest and other incomePretax income$9.7M
Pretax incomeTax and other$21.0M
Pretax incomeNet income$22.9M

Revenue and net profit

Revenue grew 22.3% in FY2025; net profit is the dashed line.

Privia Health Group, Inc. revenue and net profit by fiscal year
Privia Health Group, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$1.4B-$8.6M
FY2023$1.7B$23.1M
FY2024$1.7B$14.4M
FY2025$2.1B$22.9M

Cash flows

FY2025: $163.4M from operations, $163.4M free after investment (dashed).

Privia Health Group, Inc. operating and free cash flow by fiscal year
Privia Health Group, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$47.2M$47.2M
FY2023$80.8M$80.8M
FY2024$109.3M$109.3M
FY2025$163.4M$163.4M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$2.1B+22.3%1Y
EBITDA
$44.1M+82.0%1Y
Net profit
$22.9M+59.3%1Y
Cash from operations
$163.4M+49.5%1Y
Free cash flow
$163.4M+49.5%1Y
Revenue CAGR, 3Y
16.1%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$2.1B$44.1M$22.9M$163.4M3.1%+22.3%+59.3%

Monthly returns

Month-by-month returns of PRVA across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$1.4B
Liabilities$578.4M
Equity$790.9M
Paid-in capital$892.3M
Retained earnings-$156.3M
Minority interest$53.7M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; PRVA highlighted.

P/E against peers

PRVA trades at 117.5x earnings against a peer median of 12.1x (a 868% premium).

Not shown (no positive earnings and no EV / Sales): Arcus Biosciences, Inc., Supernus Pharmaceuticals, Inc., Acadia Healthcare Company, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Privia Health Group, Inc.PRVAthis companyP/E ↑ premium$2.7B117.5x3.7x3.1%50.4x
Concentra Group Holdings Parent, Inc.CON$3.2B19.2x8.1x42.3%12.7x
Integer Holdings CorporationITGR$3.1B30.6x1.8x5.9%15.2x
Arcus Biosciences, Inc.RCUS$3.1B-8.8x4.9x-55.9%-8.9x
National HealthCare CorporationNHC$2.9B24.5x2.7x11.2%13.7x
Supernus Pharmaceuticals, Inc.SUPN$2.6B-67.3x2.4x-3.6%58.9x
TransMedics Group, Inc.TMDX$2.5B13.0x5.2x40.2%16.8x
Acadia Healthcare Company, Inc.ACHC$2.3B-2.1x1.2x-56.6%-6.5x
Prestige Consumer Healthcare Inc.PBH$2.2B11.3x1.1x10.1%9.5x
Peer median—12.1x2.6x8.0%13.2x

Year-to-date ROI

PRVA since 1 January, against earlier years.

Historical volatility

PRVA's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Privia Health Group, Inc. operating margin by fiscal year
Privia Health Group, Inc. operating margin by fiscal year
DateOperating margin
FY2022-1.4%
FY20231.2%
FY20241.0%
FY20251.6%
LineFY2025
Cost of revenueCost Of Revenue$1.9B
Gross profitGross Profit$209.4M
Operating expensesOperating Expense$175.2M
Depreciation and amortisationDepreciation And Amortization In Income Statement$9.9M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$9.9M
Total expensesTotal Expenses$2.1B
Pretax incomePretax Income$43.9M

Learn while you research

Academy chapters picked for Privia Health Group, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Valuation Multiples ExplainedThis stock trades at a P/E of 117.5, learn when high multiples are justified.6 min read
  3. 03 Growth Investing22% revenue growth is in the top tier, learn how to value growth.7 min read
  4. 04 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  5. 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  6. 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →